Cliff Asness's BRKR Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 36,007 shares of Bruker Corporation (BRKR) worth $1.12 M, representing 0.00% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in BRKR, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2025, adding 1.85 M shares. Largest reduction occurred in Q3 2025, reducing 3.29 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Bruker Corporation (BRKR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bruker Corporation (BRKR) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2013 | +28,000 | New Buy | 28,000 | $19.79 |
| Q1 2014 | -16,500 | Reduce 58.93% | 11,500 | $22.78 |
| Q2 2014 | +9,100 | Add 79.13% | 20,600 | $24.27 |
| Q3 2014 | +61,500 | Add 298.54% | 82,100 | $18.51 |
| Q4 2014 | -4,800 | Reduce 5.85% | 77,300 | $19.62 |
| Q1 2015 | -77,300 | Sold Out | 77,300 | $0.00 |
| Q3 2015 | +13,910 | New Buy | 13,910 | $16.46 |
| Q4 2015 | +20,917 | Add 150.37% | 34,827 | $24.26 |
| Q1 2016 | +1.23 M | Add 3525.04% | 1.26 M | $28.00 |
| Q2 2016 | +1.14 M | Add 89.91% | 2.4 M | $22.74 |
| Q3 2016 | +1.11 M | Add 46.46% | 3.51 M | $22.65 |
| Q4 2016 | +159,274 | Add 4.54% | 3.67 M | $21.18 |
| Q1 2017 | -632,467 | Reduce 17.23% | 3.04 M | $23.33 |
| Q2 2017 | -371,873 | Reduce 12.24% | 2.67 M | $28.84 |
| Q3 2017 | -639,256 | Reduce 23.97% | 2.03 M | $29.75 |
| Q4 2017 | -536,779 | Reduce 26.48% | 1.49 M | $34.32 |
| Q1 2018 | +7,596 | Add 0.51% | 1.5 M | $29.92 |
| Q2 2018 | +249,402 | Add 16.65% | 1.75 M | $29.04 |
| Q3 2018 | +496,259 | Add 28.40% | 2.24 M | $33.45 |
| Q4 2018 | -151,163 | Reduce 6.74% | 2.09 M | $29.77 |
| Q1 2019 | -390,592 | Reduce 18.67% | 1.7 M | $38.44 |
| Q2 2019 | -56,391 | Reduce 3.31% | 1.65 M | $49.95 |
| Q3 2019 | -1.11 M | Reduce 67.72% | 531,191 | $43.93 |
| Q4 2019 | -349,679 | Reduce 65.83% | 181,512 | $50.62 |
| Q1 2020 | +99,441 | Add 54.78% | 280,953 | $35.86 |
| Q2 2020 | -89,311 | Reduce 31.79% | 191,642 | $39.85 |
| Q3 2020 | +43,385 | Add 22.64% | 235,027 | $39.75 |
| Q4 2020 | -203,281 | Reduce 86.49% | 31,746 | $53.17 |
| Q1 2021 | -5,490 | Reduce 17.29% | 26,256 | $63.68 |
| Q2 2021 | +55,443 | Add 211.16% | 81,699 | $75.50 |
| Q3 2021 | +130,855 | Add 160.17% | 212,554 | $78.10 |
| Q4 2021 | +82,635 | Add 38.88% | 295,189 | $83.91 |
| Q1 2022 | +100,334 | Add 33.99% | 395,523 | $64.30 |
| Q2 2022 | +73,098 | Add 18.48% | 468,621 | $61.65 |
| Q3 2022 | -109,329 | Reduce 23.33% | 359,292 | $53.06 |
| Q4 2022 | -206,069 | Reduce 57.35% | 153,223 | $68.31 |
| Q1 2023 | -52,088 | Reduce 33.99% | 101,135 | $78.39 |
| Q2 2023 | -7,150 | Reduce 7.07% | 93,985 | $73.92 |
| Q3 2023 | +151,460 | Add 161.15% | 245,445 | $62.30 |
| Q4 2023 | +19,812 | Add 8.07% | 265,257 | $73.48 |
| Q1 2024 | -16,810 | Reduce 6.34% | 248,447 | $93.41 |
| Q2 2024 | +307,021 | Add 123.58% | 555,468 | $63.81 |
| Q3 2024 | +194,621 | Add 35.04% | 750,089 | $69.06 |
| Q4 2024 | +140,000 | Add 18.66% | 890,089 | $58.62 |
| Q1 2025 | +586,516 | Add 65.89% | 1.48 M | $41.10 |
| Q2 2025 | +1.85 M | Add 125.30% | 3.33 M | $41.20 |
| Q3 2025 | -3.29 M | Reduce 98.92% | 36,007 | $31.11 |
Cliff Asness's Bruker Corporation Investment FAQs
Cliff Asness first purchased Bruker Corporation (BRKR) in Q4 2013, acquiring 28,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Bruker Corporation (BRKR) for 48 quarters since Q4 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to Bruker Corporation (BRKR) was in Q2 2025, adding 3,326,820 shares worth $137.06 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 36,007 shares of Bruker Corporation (BRKR), valued at approximately $1.12 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bruker Corporation (BRKR) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in Bruker Corporation (BRKR) was 3,670,912 shares, as reported at the end of Q4 2016. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.